PPAPDC2 exhibits diphosphate phosphatase activity with distinct substrate preferences:
| Substrate | Relative Activity | Optimal Conditions |
|---|---|---|
| Presqualene diphosphate (PSDP) | Highest | pH 7.0–8.0, Mg²⁺-independent |
| Farnesyl diphosphate (FDP) | Moderate | pH 7.0–8.0 |
| Phosphatidic acid | Low | pH 7.0–8.0 |
In vitro studies demonstrate that PPAPDC2 hydrolyzes PSDP to PSMP, a bioactive lipid involved in neutrophil signaling . It also dephosphorylates FDP and geranylgeranyl diphosphate (GGPP), intermediates in sterol synthesis and protein prenylation .
Regulation of Rho GTPases: Overexpression of PPAPDC2 in mammalian cells reduces membrane-associated RhoA levels by 69%, impairing cytoskeletal organization and cell motility .
Sterol Metabolism: In yeast, PPAPDC2 overexpression depletes farnesyl diphosphate pools, causing sterol auxotrophy and growth defects .
Interconversion of Isoprenoids: PPAPDC2 modulates cellular levels of isoprenoid phosphates, as shown using synthetic isoprenol reporters like anilinogeraniol (AGOH) .
Isoprenoid Phosphate Metabolism: Used to study enzymatic pathways converting isoprenols to isoprenoid diphosphates .
Protein Prenylation Studies: PPAPDC2 overexpression reduces protein isoprenylation, aiding investigations into GTPase function .
Disease Models: Insights into dysregulated lipid signaling in immune disorders or cancers .
While mammalian PPAPDC2 shares functional similarities with lipid phosphate phosphatases (LPPs), key differences include:
| Feature | PPAPDC2 | Mammalian LPPs |
|---|---|---|
| Substrate Preference | PSDP > FDP > phospholipids | Broad phospholipid substrates |
| Cellular Localization | Endoplasmic reticulum, nuclear envelope | Plasma membrane |
| Physiological Impact | Severe growth defects upon overexpression | Mild effects on cell proliferation |
PPAPDC2’s unique orientation in membranes (cytoplasmic-facing catalytic domain) distinguishes it from LPPs .
Handling: Lyophilized protein should be reconstituted gently to avoid aggregation .
Activity Assays: Use radiolabeled PSDP or mass spectrometry-based methods for quantitative analysis .
Controls: Include catalytically inactive mutants (e.g., site-directed mutants of the HxKxxxxD motif) to validate results .
STRING: 7955.ENSDARP00000074783
UniGene: Dr.143825